Diagnostic value of serum CA19-9 in pancreatic cancer: a systematic review and meta-analysis
| Main Authors: | Bo-qiang Zhao, Bo-yue Zhao, Fang-yao Chen |
|---|---|
| Format: | info Image Journal |
| Terbitan: |
, 2021
|
| Online Access: |
https://zenodo.org/record/4741980 |
Daftar Isi:
- Table S1. Complete information of inclusion research Figure S1-18. Summarized effect size for subgroup analysis Figure S1. Summarized effect size for Retrospective (link to Table 2 Part 1) Figure S2. Summarized effect size for Prospective (link to Table 2 Part 1) Figure S3. Summarized effect size for Subgroup analysis I(link to Table 2 Part 2) Figure S4. Summarized effect size for Subgroup analysis II(link to Table 2 Part 2) Figure S5. Summarized effect size for Subgroup analysis III(link to Table 2 Part 2) Figure S6. Summarized effect size for Subgroup analysis I(link to Table 2 Part 3) Figure S7. Summarized effect size for Subgroup analysis II(link to Table 2 Part 3) Figure S8. Summarized effect size for Subgroup analysis III(link to Table 2 Part 3) Figure S9. Summarized effect size for PC/CP+AP (link to Table 2 Part 4) Figure S10. Summarized effect size for PDAC/CP+AP (link to Table 2 Part 4) Figure S11. Summarized effect size for IPMN (link to Table 2 Part 4) Figure S12. Summarized effect size for Diabetes (link to Table 2 Part 4) Figure S13. Summarized effect size for AIP (link to Table 2 Part 4) Figure S14. Summarized effect size for 37.0U/ml (link to Table 2 Part 5) Figure S15. Summarized effect size for <37.0U/ml (link to Table 2 Part 5) Figure S16. Summarized effect size for 37.0-100.0U/ml (link to Table 2 Part 5) Figure S17. Summarized effect size for >100.0U/ml (link to Table 2 Part 5) Figure S18. Summarized effect size for Optimum (link to Table 2 Part 5)